• R. Weiss, S. Scheiblhofer, J. Thalhamer: Generation and Evaluation of Prophylactic mRNA Vaccines Against Allergy. (wikipedia.org)
  • The COVID-19 pandemic brought mRNA vaccines into the limelight. (nationalgeographic.com)
  • Whereas the COVID-19 vaccines are preventative, mRNA vaccines for cancer are therapeutic, and Cassidy jumped at the opportunity to participate. (nationalgeographic.com)
  • But while the mRNA approach seems revolutionary, long before anyone had heard of COVID-19, researchers had been developing mRNA vaccines to fight cancer, autoimmune diseases such as multiple sclerosis , and to protect against other infectious diseases, such as the respiratory syncytial virus . (nationalgeographic.com)
  • It's not a new idea: What COVID has shown us is that mRNA vaccines can be an efficacious and safe technology for millions of people," says Daniel Anderson, a leader in the field of nanotherapeutics and biomaterials at the Massachusetts Institute of Technology and a member of the Koch Institute for Integrative Cancer Research. (nationalgeographic.com)
  • Currently, phase one and phase two clinical trials are recruiting participants or are underway to assess the efficacy, tolerability, and safety of therapeutic mRNA vaccines to treat various forms of cancer. (nationalgeographic.com)
  • The two most successful coronavirus vaccines developed in the U.S. - the Pfizer and Moderna vaccines - are both mRNA vaccines. (nextgov.com)
  • We spoke to her about the future of mRNA vaccines for The Conversation Weekly podcast. (nextgov.com)
  • The mRNA vaccines did not work very well at first. (nextgov.com)
  • But about seven or eight years ago, mRNA vaccines started to take the lead. (nextgov.com)
  • DNA and mRNA vaccines are much better at producing T cells than are normal vaccines. (nextgov.com)
  • Especially, DNA and mRNA vaccines have been identified as primary and rapid responses in the current global COVID-19 outbreak. (hamiltoncompany.com)
  • As an important part of immunotherapy, cancer vaccines have unique and significant advantages against prostate cancer, including monocyte vaccines and dendritic cells,accines, viral vaccines, peptide vaccines and DNA/mRNA vaccines [9]. (asmepress.com)
  • A genetic vaccine (also gene-based vaccine) is a vaccine that contains nucleic acids such as DNA or RNA that lead to protein biosynthesis of antigens within a cell. (wikipedia.org)
  • Here, we demonstrated that intradermal administration of clinically relevant vaccines efficiently induces Trm cells specific for tumor-specific and self-antigens that accumulate in vaccinated and non-vaccinated skin. (lifeboat.com)
  • Here we demonstrated that a single intradermal administration of gene- or protein-based vaccines efficiently induces specific Trm cell responses against models of tumor-specific and self-antigens, which accumulated in vaccinated and distant non-vaccinated skin. (lifeboat.com)
  • Immunotherapy is emerging as a new form to treat cancer by harnessing the activity of cytotoxic CD8 + T lymphocytes (CTLs) that specifically recognize tumor-associated antigens. (lifeboat.com)
  • Information about these antigens can be encoded in several ways, including as DNA, RNA, or even protein fragments, which Klaeger noted, "allows for faster development and production as we don't need to grow a lot of virus. (cancerresearch.org)
  • In the lab of renowned cancer vaccine specialist Cathy Wu, MD, Klaeger is optimizing a method to identify which antigens make the best targets for vaccines. (cancerresearch.org)
  • The MERS DNA vaccine candidate is being developed using Inovio's DNA Medicines platform to deliver optimised synthetic antigenic genes into cells, where they are translated into protein antigens that activate an individual's immune system to generate robust targeted T cell and antibody responses. (pipelinereview.com)
  • Jiang, who is also an associate and her team developed a DNA-barcoded method that categorizes thousands of TCRs and their antigens in just two days. (utexas.edu)
  • Jiang used synthesized strips of DNA molecules as templates to create a large library of peptide antigens in test tubes. (utexas.edu)
  • The DNA molecules serve as individual barcode IDs, and using high-throughput sequencing, they can be read to discover which specific antigen or antigens bind to the individual TCRs, in a way that is significantly faster and more efficient than previous methods. (utexas.edu)
  • In general, there are two types of T-cell-based cancer immunotherapies: One is to engineer a patient's T cells with a new TCR that recognizes cancer antigens and will direct T cells to kill cancer cells. (utexas.edu)
  • Cancer vaccines use tumor cell-associated antigens to induce a specific anti-tumor immune response that is durable and robust. (asmepress.com)
  • In recent years, immunotherapies have led to remarkable strides in treating certain cancers. (mdpi.com)
  • When doctors removed the tumor from her collarbone, they told her that she might be eligible to join a clinical trial at the University of Arizona Cancer Center that was testing an mRNA (messenger ribonucleic acid) vaccine-similar technology to the Pfizer and Moderna COVID-19 vaccines-in combination with an immunotherapy drug to treat colorectal and head and neck cancers. (nationalgeographic.com)
  • This discovery really prompted additional thinking about how researchers could use nucleic acid vaccines not just for infectious diseases, but also for immunotherapy to treat cancers and chronic infectious diseases - like HIV, hepatitis B and herpes - as well as autoimmune disorders and even for gene therapy. (nextgov.com)
  • How can a vaccine treat cancers or chronic infectious diseases? (nextgov.com)
  • There are dozens of ongoing trials testing the efficacy of mRNA or DNA vaccines to treat cancers or chronic diseases. (nextgov.com)
  • Both DNA and RNA viruses have been linked with human cancers. (fun-mooc.fr)
  • Epstein-Barr virus, papillomaviruses, hepatitis B virus, human herpesvirus-8 and Merkel cell polyomavirus are the five DNA viruses that are capable of causing the development of human cancers. (fun-mooc.fr)
  • The gold rush of immunotherapy in all cancers has, of course, also hit colon cancer. (onclive.com)
  • Prostate acid phosphatase (PAP) is expressed in approximately 95% of prostate cancers and is mainly limited to prostate tissue, which is a target for prostate cancer tumor vaccine development. (asmepress.com)
  • SAN DIEGO, CA / ACCESSWIRE / February 9, 2016 / Inovio Pharmaceuticals Inc. (NASDAQ: INO) a developer of deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases, recently surged on news of the company working on a Zika vaccine. (redchip.com)
  • 90% of pancreatic cancers (PC) and may be an appropriate immunotherapy target. (bmj.com)
  • Immuno Cure focuses on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented "PD-1-enhanced DNA Vaccine Platform" and "Anti-Δ42PD1 Antibody Platform" with two DNA vaccine candidates, ICVAX and ICCOV, currently in clinical trials. (media-outreach.vn)
  • Immuno Cure will continue to be at the frontier of DNA medicines, antibodies and innovative immunotherapies, conducting R&D on novel and effective vaccine technologies to enhance our arsenal against cancers and infectious diseases. (media-outreach.vn)
  • We believe that Immuno Cure's technologies have innovative applications of immunotherapies for not only infectious diseases but also cancers and other ailments down the line, and have the potential to truly change the world. (media-outreach.vn)
  • September 15, 2023 - Vaccine targets six flu strains. (nih.gov)
  • Our group has explored the use of genomic RNA/phage display libraries derived from primary human malignant melanoma cells as a means of identifying antibody detectable targets on cancer cells (cancer vaccines or antibody guided therapeutics). (mayo.edu)
  • In the current proposal, we hypothesize that reacting COVID serum from patients that have recovered from COVID infection and compare to non-infected self-serum (if available) and control healthy volunteer serum (available in our lab) may identify protein targets that have developed as a result of the COVID infection and could be useful in the development of a COVID vaccine as well as a serologic test for anti-COVID immunity. (mayo.edu)
  • Neoantigens derived from tumor-specific mutations are promising targets for immunotherapy. (bmj.com)
  • A lot of what we've done has been predicated on various immunologic approaches that included carbohydrate, DNA, and naked DNA vaccines, as well as antibody drug conjugates directed against a variety of cell surface targets. (urologytimes.com)
  • TIME-related RNA or RNA regulators could be promising targets for anticancer immunotherapy. (biomedcentral.com)
  • They represent ideal targets for the development of therapeutic vaccines against HPV infections and HPV-associated neoplasia. (johnshopkins.edu)
  • Its polymerases provide a wide range of applications for DNA amplification, repair, sequencing, detection, and modification of genetic targets of clinical value. (globaldata.com)
  • The sequencing of the tumor DNA is followed by AI-powered identification of the most promising therapeutic targets developed by Evaxion's proprietary PIONEER™ technology. (advfn.com)
  • FlowVax is an immunotherapy solution which targets a marker on many types of cancer cells which is not present on normal cells. (flowpharma.com)
  • VEGF-targeted active immunotherapies are based on different approaches, from DNA vaccines to peptide or protein-based vaccines [13, 14]. (researchsquare.com)
  • This is the second time Evaxion has conducted a clinical trial with personalized cancer immunotherapy, having previously used a peptide-based treatment. (advfn.com)
  • September 20, 2023 - Novel vaccine includes NIH-funded technology in development since 2004. (nih.gov)
  • February 3, 2023 - New inoculation based on Ebola VSV vaccine concept. (nih.gov)
  • a biopharmaceutical company dedicated to the discovery and development of novel immunotherapies for cancer and infectious diseases. (biorxiv.org)
  • Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer, bacterial diseases, and viral infections. (advfn.com)
  • ROCKVILLE, Md.--( BUSINESS WIRE )-- Immunomic Therapeutics Inc., ("ITI"), a privately-held clinical-stage biotechnology company pioneering the study of LAMP-mediated nucleic acid-based immunotherapy, announced today that the data from two posters are being presented at the American Association for Cancer Research (AACR) Annual Meeting 2022 held in New Orleans, Louisiana, from April 8-13. (biospace.com)
  • December 28, 2022 - A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma. (nih.gov)
  • October 12, 2022 - For some people with melanoma, pembrolizumab (Keytruda) before surgery may be better than getting the immunotherapy only after surgery, a new study shows. (nih.gov)
  • In 2022, Balko helped identify the cause of myocarditis in cancer patients undergoing immunotherapy, which will lead to safer treatments for patients who require immune checkpoint inhibitors. (vanderbilt.edu)
  • COPENHAGEN, Denmark, May 10, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases, announced today that it has successfully produced all batches of personalized cancer immunotherapies for all patients enrolled in the Phase 1/2a clinical trial of EVX-02 in adjuvant melanoma. (advfn.com)
  • This presentation reports results of pre-clinical mouse studies of a cancer vaccine that promotes potent, antigen-specific CD4 T cell responses to MCPγV-LT. The majority of Merkel cell carcinomas (MCC), a rare and highly aggressive type of neuroendocrine skin cancer, are associated with Merkel cell polyomavirus (MCPyV) infection. (biospace.com)
  • To activate antigen-specific CD4 T cells in vivo, the investigators utilized the nucleic acid vaccine platform, UNITE (UNiversal Intracellular Targeted Expression), which fuses a tumor-associated antigen with lysosomal-associated membrane protein 1 (LAMP1). (biospace.com)
  • Inovio's immunotherapies function exclusively in vivo, and have generated an antigen-specific immune response against targeted diseases in all clinical trials to date. (pipelinereview.com)
  • Plasmid DNA encoding antigen of interest, such as capsid protein L1 and L2 (for preventive vaccines) and non-structural proteins E6 and E7 (for therapeutic vaccines) enters the host and stimulates an antigen-specific humoral and cellular immune response. (johnshopkins.edu)
  • What is very challenging about any sort of immunotherapy, and in particular the checkpoint inhibitors, is that you need to get the treating product or the immune cells into the tumor microenvironment, which in the case of prostate cancer, happens to be the bone. (urologytimes.com)
  • Most vaccines other than live attenuated vaccines and genetic vaccines are not taken up by MHC-I-presenting cells, but act outside of these cells, producing only a strong humoral immune response via antibodies. (wikipedia.org)
  • As a result, genetic vaccines and live vaccines generate cytotoxic T-cells in addition to antibodies in the vaccinated individual. (wikipedia.org)
  • Phage, expressing melanoma cDNA express the proteins/peptides on their capsid are "recognized" by the immobilized antibodies are retained in the column, and subsequently eluted for DNA sequencing. (mayo.edu)
  • Comparison of the DNA profiles of the eluted phage using pre-immunotherapy and post-immunotherapy patient sera will reveal emergence of new antibodies (post-immunotherapy gain of antibodies) against proteins of potential interest for melanoma targeting. (mayo.edu)
  • He told a news briefing at the 3rd European Breast Cancer Conference in Barcelona: "The objective of our vaccine is to stimulate the patient's own immune system and to see whether we can induce it to launch specific killer cells as well as producing HER-2 specific antibodies. (innovations-report.com)
  • Led by the AEF Greater Bay Area Fund that Gobi Partners GBA (" Gobi GBA ") manages, this round will be used to accelerate the development of DNA vaccines and antibodies, as well as to prepare for an initial public offering (" IPO ") in Hong Kong. (media-outreach.vn)
  • However, its efficacy in adults remains inconsistent underlying the urgency for innovative research to develop more effective vaccines against this resilient pathogen. (nature.com)
  • While DNA vaccines were more frequently researched in the early years due to their ease of production, low cost, and high stability to degrading enzymes, but sometimes produced low vaccine responses despite containing immunostimulatory CpG sites, more research was later conducted on RNA vaccines, whose immunogenicity was often better due to inherent adjuvants and which, unlike DNA vaccines, cannot insert into the genome of the vaccinated. (wikipedia.org)
  • The candidate encoding the longest RBD variant (VB2060) demonstrated high secretion of a functional protein and induced rapid and dose-dependent RBD IgG antibody responses that persisted up to at least 3 months after a single dose of the vaccine in mice. (biorxiv.org)
  • We compared the humoral and cellular immune responses obtained after DNA vaccination to other vaccine modalities. (cancer.gov)
  • Most vaccines induce antibody responses. (nextgov.com)
  • ROCKVILLE, Md.--( BUSINESS WIRE )-- Immunomic Therapeutics , Inc. will present data on its investigational nucleic acid platform, UNITE (UNiversal Intracellular Targeted Expression), that elicits potent immune responses and inhibits tumor growth when used with its investigational vaccine, ITI-4000, in mice. (biospace.com)
  • Immunomic Therapeutics, Inc. (ITI) is a privately-held, clinical stage biotechnology company pioneering the development of vaccines through its proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE), which is designed to utilize the body's natural biochemistry to develop vaccines that generate broad immune responses. (biospace.com)
  • With tenure granted in 2021, Ascano's findings illuminate critical host-viral pathogen interactions and cellular immune responses, thereby facilitating the development of novel vaccines and immunotherapies. (vanderbilt.edu)
  • However all 4 of the vaccine epitopes with strongest ELISpot responses were absent in the adrenal lesion, consistent with neoantigen loss resulting from immune editing and subsequent clonal escape. (bmj.com)
  • Each approach has potential advantages - DNA is generally believed to be a good way to get a response from cytotoxic T cells, while protein is better at inducing antibody responses," he said. (innovations-report.com)
  • We know that already from the variable responses to chemotherapy, radiotherapy, endocrine treatment and other immunotherapies. (innovations-report.com)
  • Evaluation of celular [sic] and humoral immune responses in vaccinated humans with different preparations of a vaccine made of killed promastigote strains of leishmania / Marco Victor Hermeto. (who.int)
  • We optimized the formulations and delivery of DNA vaccines using molecular adjuvants, liposomes, nanoparticle formulations and electroporation. (cancer.gov)
  • We tested different adjuvants for their compatibility with DNA vaccine protocols and developed shortened protocols able to produce a strong humoral immune response. (cancer.gov)
  • The search for new approaches to overcome these severe side effects has led to novel technical methods such as live vector or DNA vaccines, although the use of innovative adjuvants combined with selected amyloid peptides is among the most auspicious. (benthamscience.com)
  • This study paves the way for better design of more efficient CaPs loaded with different types of CpGs for immunostimulation applications as vaccine adjuvants. (rsc.org)
  • Martinon demonstrated that a cellular immune response was induced by vaccination with an RNA vaccine. (wikipedia.org)
  • In 1995, Robert Conry and colleagues described that a humoral immune response was also elicited after vaccination with an RNA vaccine. (wikipedia.org)
  • Our overall goal was to improve DNA and nucleic acid vaccination technologies so that these became rapid, safe, and effective vaccine platforms for AIDS, cancer and other diseases. (cancer.gov)
  • DNA vaccination has distinct advantages, including that it provides a broad priming of the immune system that may result in a robust and effective immune response. (cancer.gov)
  • Rapid advances in the efficiency of DNA vaccination made this approach very promising for the development of safe and effective vaccines with distinct advantages for many indications, including AIDS and cancer. (cancer.gov)
  • We used molecular biology techniques and animal models to test new vectors, new technologies and new combinations for DNA vaccination. (cancer.gov)
  • We used different DNA vaccine delivery procedures to discover optimal methods of DNA vaccination. (cancer.gov)
  • As new cases of coronavirus infection continue to rise across the U.S. and around the world, many are asking when a vaccine to protect against infection will become widely available. (cancerresearch.org)
  • Scientists, companies, regulators, and others are working with urgency to shorten the time it takes to develop an effective vaccine to prevent coronavirus infection. (cancerresearch.org)
  • Meanwhile, cancer immunotherapy research is also helping advance treatments for patients suffering from COVID-19, the disease caused by the novel coronavirus. (cancerresearch.org)
  • OSLO, NORWAY I January 23, 2020 I CEPI, the Coalition for Epidemic Preparedness Innovations, today announced the initiation of three programmes to develop vaccines against the novel coronavirus, nCoV-2019. (pipelinereview.com)
  • Our intention with this work is to leverage our work on the MERS coronavirus and rapid response platforms to speed up vaccine development. (pipelinereview.com)
  • As part of their partnering agreement with CEPI, the University of Queensland will use their molecular-clamp vaccine platform to produce vaccines against known pathogens, including Middle East Respiratory Syndrome coronavirus (MERS-CoV) and will evaluate the safety and immune response of the Influenza and MERS-CoV candidates in a phase 1 clinical trial in humans. (pipelinereview.com)
  • Our EVX-02 program (NCT04455503) treats adjuvant melanoma patients with our patented DNA-based immunotherapy in combination with standard of care. (advfn.com)
  • These posters to be presented at the AACR Meeting focus on the investigational nucleic acid platform, UNITE™ (UNiversal Intracellular Targeted Expression) for two vaccines, ITI-3000 for Merkel cell carcinoma (targeting the large T antigen of the Merkel cell polyomavirus) and Her2/Neu-LAMP DNA vaccine, both of which fuse a tumor associated antigen with lysosomal associated membrane protein 1 (LAMP-1). (biospace.com)
  • Sipuleucel-T (Provenge®, Dendreon, USA) is an active immune cell-based immunotherapy that induces an immune response against prostate acid phosphatase (PAP). (asmepress.com)
  • This antigen sequence represents the complete Bevacizumab binding site and using RFASE as adjuvant, the vaccine (hVEGF 26-104 /RFASE) induces an immune response with VEGF neutralizing activity and anti-tumor effect [15]. (researchsquare.com)
  • Accordingly, the first RNA- and DNA-based vaccines approved for humans were RNA and DNA vaccines used as COVID vaccines. (wikipedia.org)
  • We here describe the development of novel COVID-19 DNA plasmid vaccines encoding homodimers consisting of a targeting unit that binds chemokine receptors on antigen-presenting cells (human MIP-1α /LD78β), a dimerization unit (derived from the hinge and C H 3 exons of human IgG3), and an antigenic unit (Spike or the receptor-binding domain (RBD) from SARS-CoV-2). (biorxiv.org)
  • These findings, together with the simplicity and scalability of plasmid DNA manufacturing, safety data on the vaccine platform in clinical trials, low cost of goods, data indicating potential long term storage at +2° to 8°C and simple administration, suggests the VB2060 candidate is a promising second generation candidate to prevent COVID-19. (biorxiv.org)
  • Back when people first heard about Pfizer-BioNTech and Moderna's COVID-19 vaccines, the mRNA technology behind them sounded like the stuff of science fiction. (nationalgeographic.com)
  • ICCOV, a preventive COVID-19 DNA vaccine candidate, has entered the Phase IIa clinical trial in Hong Kong, which is designed as an open-label study to evaluate the immunogenicity and safety of ICCOV as a booster vaccine in a total of 60 healthy adult volunteers between 18 and 75 years of age. (media-outreach.vn)
  • A New Vaccine for COVID-19. (flowpharma.com)
  • The methods (RNA or codon optimization to increase mRNA stability transport and expression) had applications in both DNA and viral vaccine vectors and also in gene therapy protocols. (cancer.gov)
  • Issels® Integrative Immuno-Oncology uses non-toxic vaccine and cell therapy that is prepared from the patient's own blood. (issels.com)
  • In my clinical trials, for example, we combine immunotherapy with immunogenic chemotherapy or radiation therapy," Kyte explained. (oslocancercluster.no)
  • Finally, we propose that the combination of DCs based vaccine and other therapy is worth further study. (medsci.org)
  • So a lot of our work is looking at combining vaccines with immune therapy to see if we can stimulate it. (onclive.com)
  • Such ongoing analysis of immune response and ctDNA for monitoring tumors offers a means to dynamic cancer therapy, whereby therapeutic vaccines with evolved neoantigen panels may be designed against new, or newly unresponsive, lesions. (bmj.com)
  • Other challenges to this therapy include knowing the affinity of the CAR T cell for the antigen in question.Clearly, prostate-specific membrane antigen, or PSMA, has been a focal target for a variety of different approaches, including immunological approaches with vaccines and antibody-drug conjugates in addition to CAR T cells, and more recently, a theranostic approach with 177-lutetium PSMA-617. (urologytimes.com)
  • The complex interplay between cancer cells and the TIME influences the outcome of immunotherapy and other anticancer therapy (Fig. 1 ). (biomedcentral.com)
  • The company also operates in the field of drug development that covers immunotherapy and other biomarker-Driven targeting therapy. (globaldata.com)
  • The Issels® Immunotherapy for Cancer treatment program uses the patient's own immune cells to attack tumor cells such as gliomas with cancer vaccines and therapies that are highly personalized and non-toxic. (issels.com)
  • For more information about the highly personalized treatment protocols, non-toxic cancer vaccines, and cell therapies used by Issels® Integrative Immuno-Oncology , contact us today. (issels.com)
  • Immunotherapy is being investigated more and more for the treatment of prostate cancer, and although not many of these therapies are currently FDA-approved, mounting data shows promise. (urologytimes.com)
  • The various immunotherapy types include DNA or RNA-based vaccines, protein-based vaccines, dendritic cell vaccines, and TIL-based therapies that target various disease indications such as colorectal cancer, renal cell carcinoma, non-small cell lung cancer, bone cancer, and gynecological cancer. (thebusinessresearchcompany.com)
  • The company undertakes the development, manufacture, and marketing of gene therapies and DNA vaccines for DNA amplification and sequencing. (globaldata.com)
  • Its offers products such development of highly efficient and scalable manufacturing processes of hp DNA for use in gene therapies and DNA vaccines, expansion of technologies and production capabilities for raw materials, expansion of technologies and systems to efficiently deliver DNA to target cells in patients. (globaldata.com)
  • Genetic vaccines are based on the principle of uptake of a nucleic acid into cells, whereupon a protein is produced according to the nucleic acid template. (wikipedia.org)
  • Examples of genetic vaccines approved for use in humans include the RNA vaccines tozinameran and mRNA-1273, the DNA vaccine ZyCoV-D as well as the viral vectors AZD1222, Ad26.COV2.S, Ad5-nCoV, and Sputnik V. In addition, genetic vaccines are being investigated against proteins of various infectious agents, protein-based toxins, as cancer vaccines, and as tolerogenic vaccines for hyposensitization of type I allergies. (wikipedia.org)
  • This presentation reports results of preclinical mouse studies on a HER2/Neu-LAMP DNA vaccine that included a bicistronic DNA construct in which both the tumor antigen (HER2) fused with LAMP-1 (lysosomal- associated membrane protein 1) and sCD40L were expressed separately. (biospace.com)
  • For any given protein, once we know the genetic sequence or code, we can design an mRNA or DNA molecule that prompts a person's cells to start making it. (nextgov.com)
  • Most nasopharyngeal carcinomas express Epstein-Barr nuclear antigen 1 (EBNA1), a sequence-specific DNA-binding protein involved in maintenance of the episomal virus genome that is required for EBV latency and associated transformation. (biospace.com)
  • The DNA vaccine is injected and taken up by the cells, which then manufacture the protein, including the inserted tetanus fragments that 'wake up' the immune system and help it to respond to HER-2. (innovations-report.com)
  • Instead of a DNA vaccine that prompts the body's cells to make the necessary protein, the AutoVac protein will be made beforehand in the laboratory and injected directly as a vaccine into the patient. (innovations-report.com)
  • Much like flu vaccines prepare the person's body to defend against pathogens, cancer prevention vaccines are given to people who do not have cancer to help their body identify and destroy infections known to lead to cancer. (issels.com)
  • CEPI entered a partnering agreement in January 2019, with University of Queensland, for up to US$ 10.6 million to develop a "molecular clamp" vaccine platform, a transformative technology that enables targeted and rapid vaccine production against multiple viral pathogens. (pipelinereview.com)
  • Women diagnosed with stage III or IV ovarian cancer who undergo traditional surgery and chemotherapy will then receive monthly injections with personalized vaccines consisting of tumor-specific neo-epitopes identified from next-generation sequencing of patients' tumor DNA and RNA using a bioinformatics pipeline that extends our prior work published in the Journal of Experimental Medicine . (uconn.edu)
  • MCPyV integrates into the host genome, resulting in expression of a truncated form of the viral large T antigen (LT) in infected cells, and makes LT an attractive target for therapeutic cancer vaccines. (biospace.com)
  • However, immune editing in response to therapeutic cancer vaccines has been challenging to demonstrate in patients. (bmj.com)
  • This was achieved by optimizing DNA vaccine expression, delivery, immunogenicity as well as synergy with other vaccine modalities. (cancer.gov)
  • Previously, we showed that DNA vaccine expression in the tissues is a major limiting step for meaningful immunogenicity and we developed general methods for efficient plasmid expression. (cancer.gov)
  • The researchers included DNA encoding the fragments, into DNA that they had made in the laboratory to code for a portion of the HER-2 molecule. (innovations-report.com)
  • Passive and active immunotherapies targeted to this molecule have been developed, and they are currently in different stages of preclinical or clinical development. (researchsquare.com)
  • In recent years, immunotherapy to activate anti-cancer host immune cells to kill tumors has become a new area of research for the treatment of prostate cancer. (asmepress.com)
  • As the most important cancer vaccine based on monocytes, it is the only prostate cancer therapeutic vaccine approved by the US Food and Drug Administration at present, which plays an extremely important role in the immunotherapy of prostate cancer. (asmepress.com)
  • Currently, the complexity of immunotherapy and the specificity of prostate cancer mean that other prostate cancer vaccines have not shown expected clinical benefits in large randomized phase II and III trials, and further in-depth studies are still needed. (asmepress.com)
  • In the past decades, immunotherapy has been used to treat prostate cancer through anti-tumor effects driven by immune response. (asmepress.com)
  • Pembrolizumab has become an important therapeutic tool for prostate cancer immunotherapy [7, 8]. (asmepress.com)
  • Among them, Sipuleucel-T plays a great role in promoting prostate cancer immunotherapy. (asmepress.com)
  • Therefore, this article reviews the latest progress on prostate cancer vaccine, especially Sipuleucel-T vaccine based on mononuclear cells. (asmepress.com)
  • Figure 1 shows that general view of vaccine for prostate cancer. (asmepress.com)
  • General view of vaccine for prostate cancer (DC, dendritic cell). (asmepress.com)
  • At the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies, Susan F. Slovin, MD, PhD , gave a presentation on immunotherapy in advanced prostate cancer, 1 reiterating the significant impact that this mode of treatment has had on patients with this disease. (urologytimes.com)
  • Please highlight the main points from your talk on immunotherapy in advanced prostate cancer. (urologytimes.com)
  • While no one can predict this with certainty as vaccines development can take years, a variety of approaches are already being tested in clinical trials. (cancerresearch.org)
  • Years of research on cancer genetics and how the immune system interacts with cancer have made new vaccines and treatments possible. (issels.com)
  • The ambition is to enable faster patient recruitment from across the Nordic region, so that many more can benefit from new treatments, such as immunotherapy. (oslocancercluster.no)
  • Most types of immunotherapy also cause less side effects than traditional cancer treatments. (oslocancercluster.no)
  • Beyond these mechanisms, patent counsel must then consider whether the antiviral treatments and vaccines will be patent eligible in various global markets. (straffordpub.com)
  • Over the course of 27 weeks, Cassidy received nine injections of a personalized mRNA vaccine along with intravenous infusions of an immunotherapy drug called Pembrolizumab. (nationalgeographic.com)
  • In this study, we evaluated the effects of three different CpG oligodeoxynucleotides (ODN) and two representative nucleic acids (siRNA and DNA), when used as templates for the formation of CaPs. (rsc.org)
  • We developed and tested new technologies including nucleic acid delivery methods in vivo , prophylactic and therapeutic vaccines and immunotherapies. (cancer.gov)
  • All of these are pioneering technologies designed to speed up the development of vaccines against emerging threats such as nCoV-2019. (pipelinereview.com)
  • Also known as a neoantigen vaccine, this stimulates a patient's T cells to kill any cancer cells. (utexas.edu)
  • Here, we report evidence of immune editing in a patient treated with a therapeutic neoantigen DNA PCV from the ongoing GT-30 advanced hepatocellular carcinoma single-arm open-label multi-center phase Ib/IIa trial. (bmj.com)
  • UConn Health has started recruiting ovarian cancer patients for a phase I clinical trial of OncoImmunome, a novel genomics-driven personalized immunotherapy. (uconn.edu)
  • In preclinical studies, ITI-4000, a DNA vaccine targeting EBNA1, demonstrated robust activation of anti-tumor CD4 and CD8 T cells in vivo and promoted tumor infiltration with activated TNFα-producing CD8 T cells. (biospace.com)
  • But, the development of a vaccine by Danish pharmaceutical company Pharmexa represents an entirely novel treatment paradigm, according to Pharmexa's manager of preclinical development and immunopharmacology, Dr Dana Leach. (innovations-report.com)
  • While viral vectors have their own mechanisms to be taken up into cells, DNA and RNA must be introduced into cells via a method of transfection. (wikipedia.org)
  • Viral vectors had previously been approved as ebola vaccines. (wikipedia.org)
  • DNA probes or high-pressure liquid chromatography) is acceptable under this criterion. (cdc.gov)
  • The synthetic antigen can then be purified and rapidly manufactured into a vaccine. (pipelinereview.com)
  • So far, the most successful passive immunotherapy directed to VEGF is Bevacizumab, a monoclonal antibody that neutralizes the binding of VEGF to its receptors [5], which has been approved, in combination with chemotherapy, for the treatment of different tumors [6-12]. (researchsquare.com)
  • acr ) was generated which was further evaluated for its ability to impart protection as a booster vaccine against tuberculosis in a heterologous prime boost approach. (nature.com)
  • Patent counsel and applicants must navigate the patent eligibility challenges as companies race to develop vaccines and medications to treat viral infections. (straffordpub.com)
  • Genetic vaccines thus include DNA vaccines, RNA vaccines and viral vector vaccines. (wikipedia.org)
  • Genetic vaccines are most commonly administered by injection (intramuscular or subcutaneous) or infusion, and less commonly and for DNA, by gene gun or electroporation. (wikipedia.org)
  • Deborah Fuller is a microbiologist at the University of Washington who has been studying genetic vaccines for more than 20 years. (nextgov.com)
  • Nucleic acid vaccines are based on the idea that DNA makes RNA and then RNA makes proteins. (nextgov.com)
  • Vaccines targeting these proteins may provide an opportunity to control HPV-associated malignancies. (johnshopkins.edu)
  • Vaccines save lives by utilizing the patient's immune system to attack harmful cells. (issels.com)
  • Immunotherapy represents a new type of cancer treatment, which activates the patient's immune-system to fight off the cancer cells. (oslocancercluster.no)
  • The other is to use a set of the patient's own personalized peptides that harbor cancer mutations as vaccines. (utexas.edu)
  • The idea of using genetic material to produce an immune response has opened up a world of research and potential medical uses far out of reach of traditional vaccines. (nextgov.com)
  • In this way, ITI's vaccines (DNA or RNA) have the potential to utilize the body's natural biochemistry to develop a broad immune response including antibody production, cytokine release, and critical immunological memory. (biospace.com)
  • Our first objective is to test the safety of the vaccine, but we also want to make a preliminary evaluation of the vaccine's ability to raise an immune response. (innovations-report.com)
  • So, the vaccine - AutoVac - has been designed to help kick-start the immune response by giving the T cells a foreign agent to recognise and react against. (innovations-report.com)
  • Dr Leach said that animal tests had shown that the vaccine produced a specific immune response and there had been no adverse side effects. (innovations-report.com)